These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 26356670)
1. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis. Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670 [TBL] [Abstract][Full Text] [Related]
2. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells. Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502 [TBL] [Abstract][Full Text] [Related]
3. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. Shin I; Kim S; Song H; Kim HR; Moon A J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464 [TBL] [Abstract][Full Text] [Related]
4. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. Martowicz A; Spizzo G; Gastl G; Untergasser G BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550 [TBL] [Abstract][Full Text] [Related]
5. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection. Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707 [TBL] [Abstract][Full Text] [Related]
6. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways. Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells. Deng D; Yang S; Wang X Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412051 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells. Gao J; Yan Q; Wang J; Liu S; Yang X J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054 [TBL] [Abstract][Full Text] [Related]
10. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis. Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415 [TBL] [Abstract][Full Text] [Related]
11. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155 [TBL] [Abstract][Full Text] [Related]
12. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion. Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731 [TBL] [Abstract][Full Text] [Related]
13. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925 [TBL] [Abstract][Full Text] [Related]
14. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway. Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216 [TBL] [Abstract][Full Text] [Related]
15. Adenosine dialdehyde suppresses MMP-9-mediated invasion of cancer cells by blocking the Ras/Raf-1/ERK/AP-1 signaling pathway. Kim JH; Kim JH; Kim SC; Yi YS; Yang WS; Yang Y; Kim HG; Lee JY; Kim KH; Yoo BC; Hong S; Cho JY Biochem Pharmacol; 2013 Nov; 86(9):1285-300. PubMed ID: 23994169 [TBL] [Abstract][Full Text] [Related]
16. Mesothelin promotes invasion and metastasis in breast cancer cells. Wang Y; Wang L; Li D; Wang HB; Chen QF J Int Med Res; 2012; 40(6):2109-16. PubMed ID: 23321167 [TBL] [Abstract][Full Text] [Related]
17. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer. Sankpal NV; Fleming TP; Gillanders WE Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578 [TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Farabegoli F; Papi A; Orlandi M Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926 [TBL] [Abstract][Full Text] [Related]
19. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells. Guo J; Lan Z Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247 [No Abstract] [Full Text] [Related]
20. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. Liu P; Wilson MJ J Cell Physiol; 2012 Feb; 227(2):867-76. PubMed ID: 21898400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]